Charles Roco

Charles Roco

CTO and Cofounder at Parse Biosciences
Seattle, Washington, United States

Charles Roco is Co-Founder and CTO at Parse Biosciences. He previously served as a Graduate Research Assistant at University of Washington Bioengineering and held research roles in drug delivery, microbiology, and cell mechanics at institutions including Harvard, Wyss Institute, Virginia Tech, and University of Pennsylvania.

Parse Biosciences and Nomic Bio launch Cascade: 100M-cell dataset pairing RNA-seq with 1,000-protein secretome across 150,000+ immune perturbations, backed by GSK, Pfizer, Sanofi

Parse Biosciences and Nomic Bio launched Cascade, a consortium-backed 100-million-cell immune perturbation dataset linking single-cell transcriptomes with matched 1,000-plex secretome protein reads across 150,000+ conditions to add protein signaling data that prior transcriptomics-only resources lacked.

Seattle’s UW research, Amazon alumni and military adjacency fuel startups building high-stakes, regulation-ready AI for biotech, finance and government

A Seattle high-school intern argues that strict school AI rules illuminated why AI must be disciplined in high-stakes domains, and describes how Seattle's research institutions (notably UW and the David Baker ecosystem), Amazon alumni, and military adjacency produce founders building accountable, regulation-ready AI for biotech, finance, and government.

See all 9 stories, episodes and videos about Charles Roco.

Organizations

See all 9
  • Parse Biosciences logo
    Parse Biosciences CTO and Cofounder 2018–present · current
  • Split Biosciences Executive Officer, Director, Promoter 2018 · past
  • University of Washington Bioengineering Graduate Research Assistant 2015–2019 · past

Education

  • University of Washington Doctor of Philosophy - PhD, Bioengineering · 2015–2019
  • Virginia Tech Bachelor of Science (B.S.), Biological Systems Engineering · 2011–2015

Online